Literature DB >> 25563633

Agonist Medications for the Treatment of Cocaine Use Disorder.

S Stevens Negus1, Jack Henningfield2.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25563633      PMCID： PMC4839506          DOI： 10.1038/npp.2014.322

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN： 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  87 in total

Review 1.  Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence.

Authors:  John Grabowski; James Shearer; John Merrill; S Stevens Negus
Journal:  Addict Behav       Date:  2004-09       Impact factor: 3.913

2.  The effect of chronic amphetamine treatment on cocaine-induced facilitation of intracranial self-stimulation in rats.

Authors:  Clayton T Bauer; Matthew L Banks; S Stevens Negus
Journal:  Psychopharmacology (Berl)       Date:  2014-01-10       Impact factor: 4.530

Review 3.  Monoamine transporter inhibitors and substrates as treatments for stimulant abuse.

Authors:  Leonard L Howell; S Stevens Negus
Journal:  Adv Pharmacol       Date:  2014

4.  Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance.

Authors:  K L Preston; A Umbricht; D H Epstein
Journal:  Arch Gen Psychiatry       Date:  2000-04

Review 5.  Efficacy of psychostimulant drugs for cocaine dependence.

Authors:  Xavier Castells; Miguel Casas; Clara Pérez-Mañá; Carlos Roncero; Xavier Vidal; Dolors Capellà
Journal:  Cochrane Database Syst Rev       Date:  2010-02-17

6.  Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans.

Authors:  M Haney; A S Ward; R W Foltin; M W Fischman
Journal:  Psychopharmacology (Berl)       Date:  2001-06       Impact factor: 4.530

Review 7.  Anticonvulsants for cocaine dependence.

Authors:  S Minozzi; L Amato; M Davoli; M Farrell; A A R L Lima Reisser; P P Pani; M Silva de Lima; B Soares; S Vecchi
Journal:  Cochrane Database Syst Rev       Date:  2008-04-16

8.  Cocaine self-administration reinforced on a progressive ratio schedule decreases with continuous D-amphetamine treatment in rats.

Authors:  Keri A Chiodo; Christopher M Läck; David C S Roberts
Journal:  Psychopharmacology (Berl)       Date:  2008-07-06       Impact factor: 4.530

Review 9.  Medications development for opioid abuse.

Authors:  S Stevens Negus; Matthew L Banks
Journal:  Cold Spring Harb Perspect Med       Date:  2013-01-01       Impact factor: 6.915

Review 10.  Clinical strategies to enhance the efficacy of nicotine replacement therapy for smoking cessation: a review of the literature.

Authors:  Matthew J Carpenter; Bianca F Jardin; Jessica L Burris; Amanda R Mathew; Robert A Schnoll; Nancy A Rigotti; K Michael Cummings
Journal:  Drugs       Date:  2013-04       Impact factor: 9.546
View more
  40 in total

1.  The individual and combined effects of phenmetrazine and mgluR2/3 agonist LY379268 on the motivation to self-administer cocaine.

Authors:  Anushree N Karkhanis; Thomas J R Beveridge; Bruce E Blough; Sara R Jones; Mark J Ferris
Journal:  Drug Alcohol Depend       Date:  2016-06-25       Impact factor: 4.492

2.  Effects of lorcaserin and buspirone, administered alone and as a mixture, on cocaine self-administration in male and female rhesus monkeys.

Authors:  Gregory T Collins; Charles P France
Journal:  Exp Clin Psychopharmacol       Date:  2018-06-28       Impact factor: 3.157

3.  Amphetamine maintenance differentially modulates effects of cocaine, methylenedioxypyrovalerone (MDPV), and methamphetamine on intracranial self-stimulation and nucleus accumbens dopamine in rats.

Authors:  Amy R Johnson; Matthew L Banks; Dana E Selley; S Stevens Negus
Journal:  Neuropsychopharmacology       Date:  2018-04-19       Impact factor: 7.853

4.  Use of Preclinical Drug vs. Food Choice Procedures to Evaluate Candidate Medications for Cocaine Addiction.

Authors:  Matthew L Banks; Blake A Hutsell; Kathryn L Schwienteck; S Stevens Negus
Journal:  Curr Treat Options Psychiatry       Date:  2015-06

5.  Circumspectives: The Replacements.

Authors:  Markus Heilig; William A Carlezon
Journal:  Neuropsychopharmacology       Date:  2015-07       Impact factor: 7.853

6.  Amphetamine Reverses Escalated Cocaine Intake via Restoration of Dopamine Transporter Conformation.

Authors:  Cody A Siciliano; Kaustuv Saha; Erin S Calipari; Steve C Fordahl; Rong Chen; Habibeh Khoshbouei; Sara R Jones
Journal:  J Neurosci       Date:  2017-11-24       Impact factor: 6.167

7.  Increased Depression and Anxiety Symptoms are Associated with More Breakdowns in Cognitive Control to Cocaine Cues in Veterans with Cocaine Use Disorder.

Authors:  Gregory J DiGirolamo; Gerardo Gonzalez; David Smelson; Nathan Guevremont; Michael I Andre; Pooja O Patnaik; Zachary R Zaniewski
Journal:  J Dual Diagn       Date:  2017-11-09

8.  Pharmacotherapeutic strategies for treating cocaine use disorder-what do we have to offer?

Authors:  Laura Brandt; Thomas Chao; Sandra D Comer; Frances R Levin
Journal:  Addiction       Date:  2020-09-28       Impact factor: 6.526

9.  Efficacy of an adenovirus-based anti-cocaine vaccine to reduce cocaine self-administration and reacqusition using a choice procedure in rhesus macaques.

Authors:  Suzette M Evans; Richard W Foltin; Martin J Hicks; Jonathan B Rosenberg; Bishnu P De; Kim D Janda; Stephen M Kaminsky; Ronald G Crystal
Journal:  Pharmacol Biochem Behav       Date:  2016-09-30       Impact factor: 3.533

Review 10.  Overview of Monoamine Transporters.

Authors:  Shaili Aggarwal; Ole V Mortensen
Journal:  Curr Protoc Pharmacol       Date:  2017-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.